This article was originally published in The Rose Sheet
Executive SummarySales increase 6.7% to $138.4 mil. for fiscal first quarter (ended April 30), Gucci reports June 21. Yves Saint Laurent cosmetics sales increased 15.9% to $40 mil., while fragrance revenues were off 1% at $60.9 mil. Gucci purchased Sanofi's beauty business, which included YSL and couture, from Artemis, a holding company for Pinault-Printemps-Redoute, in November (1"The Rose Sheet" Nov. 22, 1999, p. 4). LVMH and PPR have engaged in talks to resolve disagreements surrounding PPR's alliance with Gucci. The two companies had been negotiating a sale of LVMH's 20 mil. Gucci shares for $100 per share, but the deal fell through
You may also be interested in...
In an exclusive interview with Medtech Insight, Mark Leahey, president of the Medical Device Manufacturers Association (MDMA), said the previous four Medical Device User Fee negotiations with the US FDA have set a strong foundation for the industry and the next round of negotiations should focus on tweaking past deals that are already in place. See what MDMA's president, Mark Leahey, said about it here.
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.